IL-12 induces monocyte IL-18 binding protein expression via IFN-γ

Journal of Immunology

Volumn 168, Issue 5, 2002, Pages 2282-2287

  Veenstra, Korina G ^a   Jonak, Zdenka L ^a   Trulli, Stephen ^a   Gollob, Jared A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER PATIENT; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE; NATURAL KILLER CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TH1 CELL; TH2 CELL;

EID: 0036499116     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.5.2282     Document Type: Article

References (23)

1. Cloning of a new cytokine that induces IFN-γ production by T cells
2. Interleukin-18, a proinflammatory cytokine
3. Caspase-1 processes IFN-γ inducing factor and regulates LPS-induced IFN-γ production
4. Lipopolysaccharide/endotoxin induces IL-18 via CD14 in human peripheral blood mononuclear cells in vitro
5. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB
6. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-γ, production, and expansion of natural killer cells
7. IFN-γ-inducing factor is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12
8. Interferon-γ-inducing factor elicits antitumor immunity in association with interferon-γ production
9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells
10. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18
11. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
12. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
13. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
14. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: Ability to maintain IFN-γ induction is associated with clinical response
15. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production
16. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12
17. Tumor cell responses to IFN γ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
18. Induction of circulating IL-1 receptor antagonist by IFN treatment
19. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees
20. Interleukin-1 β costimulates interferon γ production by human natural killer cells
21. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells: A role for IL-1β in the T cell-independent mechanism of resistance against intracellular pathogens
22. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells
23. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ